Inclusion Criteria:  > 18 years of age  Diagnosed with primary cutaneous lymphoma defined by either:  A board-certified dermatologist, OR Dermatology Nurse Practitioner, OR Skin punch biopsy  The presence of plaque-type primary cutaneous lymphoma lesions with at least two plaques that are at least two cm² in areas of the trunk, buttocks, or extremities that are either:  Symmetrically located on contralateral body site OR Within the same body site but separated by ≥ 1 cm Both plaques must be similar in size as much as possible Able to give informed consent under IRB approval procedures  Exclusion Criteria:  Known allergy or hypersensitivity to triamcinolone acetonide Known allergy to topical bexarotene or topical nitrogen mustard Pregnant, breastfeeding, or planning to get pregnant 4 weeks before, during, and 4 weeks after the study. Inability to provide informed consent Diagnosis of erythrodermic mycosis fungoides or Sezary syndrome Use of topical corticosteroids to target lesions within 1 week prior to baseline visit Use of radiation therapy to target lesions within 1 week prior to baseline visit